LSV Asset Management Sells 604,680 Shares of Cardinal Health, Inc. $CAH

LSV Asset Management reduced its position in Cardinal Health, Inc. (NYSE:CAH) by 98.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,100 shares of the company’s stock after selling 604,680 shares during the quarter. LSV Asset Management’s holdings in Cardinal Health were worth $2,076,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in CAH. Wellington Management Group LLP raised its holdings in shares of Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after acquiring an additional 3,511,579 shares in the last quarter. Holocene Advisors LP raised its holdings in Cardinal Health by 141.4% in the third quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock worth $302,332,000 after purchasing an additional 1,128,358 shares in the last quarter. Barclays PLC raised its holdings in Cardinal Health by 109.3% in the third quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock worth $248,658,000 after purchasing an additional 827,446 shares in the last quarter. SG Americas Securities LLC raised its holdings in Cardinal Health by 3,829.1% in the fourth quarter. SG Americas Securities LLC now owns 727,511 shares of the company’s stock worth $149,504,000 after purchasing an additional 708,995 shares in the last quarter. Finally, Victory Capital Management Inc. raised its holdings in Cardinal Health by 44.9% in the third quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock worth $352,165,000 after purchasing an additional 707,495 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Down 0.2%

CAH opened at $199.92 on Thursday. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $233.60. The company has a market cap of $46.82 billion, a P/E ratio of 30.57, a price-to-earnings-growth ratio of 1.19 and a beta of 0.53. The firm’s 50-day moving average price is $204.15 and its 200-day moving average price is $208.90.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. During the same quarter in the prior year, the company posted $2.35 earnings per share. The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, research analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio is currently 31.19%.

Analyst Ratings Changes

CAH has been the subject of a number of recent research reports. Mizuho boosted their target price on shares of Cardinal Health from $222.00 to $235.00 and gave the stock an “outperform” rating in a report on Friday, February 6th. Morgan Stanley boosted their target price on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a report on Tuesday, April 28th. William Blair initiated coverage on shares of Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating for the company. Zacks Research upgraded shares of Cardinal Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 12th. Finally, Robert W. Baird set a $248.00 target price on shares of Cardinal Health in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.